echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Illumina Announces Collaboration with Boehringer Ingelheim to Develop Companion Diagnostics

    Illumina Announces Collaboration with Boehringer Ingelheim to Develop Companion Diagnostics

    • Last Update: 2022-01-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Illumina this week announced a collaboration with Boehringer Ingelheim to develop companion diagnostics (CDx) for multiple programs in Boehringer Ingelheim's oncology pipeline
    .
    The partnership aims to help patients with advanced cancer choose treatment options and enable precision medicine


    .


    The collaboration covers current and future CDx programs, and Illumina plans to develop a companion diagnostic test based on the content of the TruSight™ Oncology 500 (TSO 500)
    .
    In the first project, they will collaborate to develop a companion diagnostic for one of Boehringer Ingelheim's clinical trial drugs


    .

    The TSO 500 is a research-only pan-cancer assay that identifies 523 known and emerging tumor biomarkers
    .
    The TSO 500 utilizes DNA and RNA from tumor samples to identify key variants critical to cancer progression, such as small DNA variants, gene fusions and splice variants


    .

    Based on the content of the TSO 500, Illumina will add an in vitro diagnostic test to the TruSight Oncology product family
    .
    This comprehensive tumor analysis approach will utilize similar chemistry and analytical methods to the TSO 500


    .

    "We are delighted that Boehringer Ingelheim has selected Illumina as its long-term partner to develop companion diagnostics for cancer treatment," said Joydeep Goswami, chief strategy and corporate development officer at Illumina.
    "Illumina


    will continue to provide leading-edge assays in tissue biopsy and liquid biopsy.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.